Author: "Huberman, M. A." / Journal: journal of clinical oncology - Searchworks@Jio Institute Digital Library Search Results

Searchworks

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources

Your search keyword '"Huberman, M. A."' showing total 8 results

Start Over Author "Huberman, M. A." Journal journal of clinical oncology

8 results on '"Huberman, M. A."'

1. Patterns of care for non-small cell lung cancer at an academic institution affiliated with a National Cancer Institute–designated cancer center: Beth Israel Deaconess Medical Center.

Author: Nguyen, K. H., primary, Huberman, M., additional, Goldstein, M., additional, Kobayashi, S., additional, and Costa, D. B., additional
Published: 2011
Full Text: View/download PDF

2. Phase II trial of erlotinib in chemotherapy-naive women with advanced pulmonary adenocarcinoma

Author: Jackman, D. M., primary, Cioffredi, L., additional, Lindeman, N. I., additional, Morse, L. K., additional, Lucca, J., additional, Weckstein, D., additional, Huberman, M. S., additional, Lynch, T. J., additional, Johnson, B. E., additional, and Janne, P. A., additional
Published: 2009
Full Text: View/download PDF

3. Lack of efficacy of erlotinib in most EGFR mutated non-small cell lung cancers (NSCLCs) with acquired resistance to gefitinib

Author: Costa, D. B., primary, Cho, B. C., additional, Sequist, L. V., additional, Riely, G. J., additional, Halmos, B., additional, Kim, J., additional, Huberman, M. S., additional, Pao, W., additional, Tenen, D. G., additional, and Kobayashi, S., additional
Published: 2008
Full Text: View/download PDF

4. Phase II trial of oxaliplatin, pemetrexed, and bevacizumab in previously-treated advanced non-small cell lung cancer (NSCLC)

Author: Heist, R. S., primary, Fidias, P., additional, Huberman, M., additional, Temel, J., additional, Sequist, L., additional, and Lynch, T. J., additional
Published: 2007
Full Text: View/download PDF

5. Phase II study of erlotinib in chemo-naive women with advanced pulmonary adenocarcinoma

Author: Jackman, D., primary, Lindeman, N. I., additional, Lucca, J., additional, Morse, L. K., additional, Rabin, M. S., additional, Marcoux, J. P., additional, Huberman, M., additional, Johnson, B. E., additional, and Janne, P. A., additional
Published: 2007
Full Text: View/download PDF

6. Phase I-II trial of TLK286, a novel glutathione analog prodrug, in combination with carboplatin (C) and paclitaxel (P) as first-line treatment for advanced non-small cell lung cancer (NSCLC)

Author: Sequist, L. V., primary, Fidias, P., additional, Temel, J., additional, Kennedy, B. A., additional, Ostler, P. A., additional, Rabin, M. S., additional, Huberman, M., additional, Keck, J., additional, Brown, G. L., additional, and Lynch, T. J., additional
Published: 2005
Full Text: View/download PDF

7. Erlotinib + gemcitabine in patients with unresectable pancreatic carcinoma: Results from a phase IB trial

Author: Porterfield, B. W., primary, Dragovich, T., additional, Patnaik, A., additional, Rowinsky, E., additional, Huberman, M., additional, Clinebell, T., additional, Hamilton, M., additional, Zitelli, A., additional, Nadler, P., additional, and Wood, D., additional
Published: 2004
Full Text: View/download PDF

8. Bevacizumab reverses cerebral radiation necrosis.

Author: Wong ET, Huberman M, Lu XQ, and Mahadevan A
Published: 2008

Catalog

Books, media, physical & digital resources

See catalog results